GPT2 and neuroblastoma: In this research, we discover that FOXC1 enhances the expression of de novo asparagine or alanine biogenesis genes, asparagine synthetase (ASNS) and glutamate pyruvate transaminase 2 (GPT2), which are linked to poor prognosis of NB patients.